Journal Basic Info
- Impact Factor: 2.395**
- H-Index: 8
- ISSN: 2474-1647
- DOI: 10.25107/2474-1647
Major Scope
- Pediatric Surgery
- Orthopaedic Surgery
- Cardiovascular Surgery
- General Surgery
- Colon and Rectal Surgery
- Bariatric Surgery
- Urology
- Vascular Surgery
Abstract
Citation: Clin Surg. 2021;6(1):3084.Research Article | Open Access
Medico-Economic Impact of the AirSeal® Insufflator: Example of Laparoscopic Sacrocolpopexy
Boualaoui I*, Bey E, De Villeneuve MH, Dergamoun H, Droupy S and Wagner L
Department of Urology and Andrology, Nimes University Hospital Center, France
*Correspondance to: Boualaoui I
PDF Full Text DOI: 10.25107/2474-1647.3084
Abstract
Introduction: AirSeal? is an insufflation system that enables a stable pneumoperitoneum during laparoscopic surgery, thus providing a permanent renewal of the abdominal gas in a closed system. The aim of this study was to evaluate the medical and economic impact of the AirSeal? system for laparoscopic sacrocolpopexy. Materials and Methods: A preliminary mono-centric retrospective study has been performed during a period of 9 months between May 2019 and February 2020. Post-operative pain was evaluated by a visual analog scale on days 0, 1, and 2. Analgesic and antiemetic use was also collected. The main intraoperative anesthesiologic parameters (morphine and curare doses, peak airways pressure, endtidal CO2 , and temperature) were also studied. The patient?s outing ability was evaluated by the CHUNG score. Results: Thirty-four consecutive patients treated by laparoscopic sacrocolpopexy have been included in the present study. The first 17 were operated using the AirSeal? system and the other half using a standard insufflating system, by the same surgeon. Mean age was 58.9 ? 12.2 years. Postoperative pain was lower in the AirSeal? system group with 40% of morphinic use vs. 52% in the standard system group. The length of stay was also shorter, with 65% of AirSeal? system patients able to leave on an ambulatory basis vs. 35% in the second group, and 95% on first day vs. 76% in the standard insufflation system group. Conclusion: These preliminary results may suggest a positive medical and economic impact of the AirSeal? insufflation system by reducing length of stay, postoperative pain and analgesic use.
Keywords
Sacrocolpopexy; Low impact laparoscopy; laparoscopy; Postoperative pain
Cite the article
Boualaoui I, Bey E, De Villeneuve MH, Dergamoun H, Droupy S, Wagner L. Medico-Economic Impact of the AirSeal® Insufflator: Example of Laparoscopic Sacrocolpopexy. Clin Surg. 2021; 6: 3084.